omniture
logo
Search
北京罕友医药科技有限公司 SPEROGENIX
Media Room

Latest News

rss

Abbisko and Sperogenix Announce An Exclusive Agreement to Develop ABSK021 for ALS and Other Rare Neurological Diseases in Greater China

SHANGHAI, BEIJING, HONG KONG, July 5, 2021 /PRNewswire/ -- Sperogenix (Shanghai ) MedTech Co., Ltd. ...

2021-07-05 08:51 1857
Abbisko and Sperogenix Announce An Exclusive Agreement to Develop ABSK021 for ALS and Other Rare Neurological Diseases in Greater China

Minoryx Therapeutics and Sperogenix Therapeutics enter into an exclusive license agreement to develop and commercialize leriglitazone in mainland China, Hong Kong and Macau

* Minoryx will receive an upfront and milestone payments of up to $78 million , as well as double ...

2020-09-23 15:00 1551